S-1 maintenance therapy in Caucasian patients with metastatic esophagogastric adenocarcinoma–final results of the randomized AIO MATEO phase II trial

PURPOSE: Platinum-fluoropyrimidine combinations are standard of care for treatment of metastatic esophagogastric adenocarcinoma. The optimal duration of first-line chemotherapy is unknown, however, and maintenance strategies have not yet been established. DESIGN: MATEO is an international randomized...

Descripción completa

Detalles Bibliográficos
Autores principales: Stocker, G., Lorenzen, S., Ettrich, T., Herz, A.-L., Longo, F., Kiani, A., Venerito, M., Trojan, J., Mahlberg, R., Moosmann, N., Chibaudel, B., Kubicka, S., Greil, R., Daum, S., Geissler, M., Larcher-Senn, J., Keller, G., Lordick, F., Haag, G.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373924/
https://www.ncbi.nlm.nih.gov/pubmed/37270871
http://dx.doi.org/10.1016/j.esmoop.2023.101572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373924/
https://www.ncbi.nlm.nih.gov/pubmed/37270871
http://dx.doi.org/10.1016/j.esmoop.2023.101572

Ejemplares similares